Cargando…
Amantadine withdrawal syndrome masquerading as COVID-19 encephalopathy: a case report and review of the literature
Amantadine withdrawal syndrome (AWS) is a rare but recognized cause of severe and persistent altered mental status sometimes with co-occurring extrapyramidal symptoms. First described in a case series from 1987, its clinical manifestations have been characterized along a spectrum ranging from profou...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885144/ https://www.ncbi.nlm.nih.gov/pubmed/33614044 http://dx.doi.org/10.1093/omcr/omaa133 |